|
Revolution Medicines Inc (NASDAQ: RVMD) |
|
RVMD's vs. Competition, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
| Revolution Medicines Inc |
RVMD |
6,546 |
30 |
-600 |
202 |
| Aceragen Inc |
ACGN |
3 |
0 |
-41 |
70 |
| Arcellx Inc |
ACLX |
3,907 |
77 |
-162 |
22 |
| Alector Inc |
ALEC |
166 |
88 |
-123 |
244 |
| Aligos Therapeutics Inc |
ALGS |
78 |
3 |
-53 |
10 |
| Allogene Therapeutics Inc |
ALLO |
265 |
0 |
-252 |
229 |
| Ambrx Biopharma Inc |
AMAM |
1,743 |
9 |
-134 |
41 |
| Amgen Inc |
AMGN |
159,467 |
33,424 |
4,090 |
24,000 |
| Apogee Therapeutics Inc |
APGE |
2,276 |
0 |
-205 |
10 |
| Aptose Biosciences Inc |
APTO |
4 |
0 |
-21 |
13 |
| Argenx se |
ARGX |
30,703 |
856 |
-710 |
700 |
| Armata Pharmaceuticals Inc |
ARMP |
144 |
5 |
0 |
8 |
| Atara Biotherapeutics Inc |
ATRA |
105 |
303 |
-16 |
153 |
| Autolus Therapeutics Plc |
AUTL |
644 |
0 |
-238 |
201 |
| Biocryst Pharmaceuticals Inc |
BCRX |
1,871 |
503 |
-53 |
197 |
| Biogen Inc |
BIIB |
18,324 |
9,816 |
1,479 |
7,570 |
| Cullinan Therapeutics Inc |
CGEM |
458 |
0 |
-179 |
111 |
| Coherus Biosciences inc |
CHRS |
103 |
197 |
-131 |
926 |
| Calidi Biotherapeutics Inc |
CLDI |
17 |
0 |
-20 |
10 |
| Compass Therapeutics Inc |
CMPX |
435 |
0 |
-55 |
106 |
| Cardiol Therapeutics inc |
CRDL |
77 |
0 |
-22 |
20 |
| Cel sci Corporation |
CVM |
272 |
0 |
-27 |
30 |
| Dyadic International Inc |
DYAI |
29 |
4 |
-6 |
34 |
| Enzon Pharmaceuticals inc |
ENZN |
6 |
2 |
0 |
0 |
| Tradeup Acquisition Corp |
ESLA |
30 |
0 |
-7 |
0 |
| Exelixis Inc |
EXEL |
12,931 |
2,299 |
1,482 |
566 |
| Fate Therapeutics Inc |
FATE |
136 |
13 |
-176 |
220 |
| Fusion Pharmaceuticals Inc |
FUSN |
1,805 |
1 |
-104 |
27 |
| Gilead Sciences Inc |
GILD |
136,249 |
28,735 |
5,965 |
18,000 |
| Gamida Cell Ltd |
GMDA |
6 |
0 |
79 |
98 |
| Genenta Science S p a |
GNTA |
0 |
0 |
-10 |
30 |
| Halozyme Therapeutics Inc |
HALO |
7,321 |
1,084 |
485 |
3,011 |
| Immunitybio inc |
IBRX |
2,414 |
31 |
-409 |
202 |
| In8bio Inc |
INAB |
184 |
0 |
-27 |
18 |
| Iovance Biotherapeutics inc |
IOVA |
756 |
213 |
-375 |
135 |
| Innate Pharma Sa |
IPHA |
149 |
69 |
-8 |
179 |
| Iteos Therapeutics Inc |
ITOS |
444 |
454 |
-131 |
157 |
| Jasper Therapeutics Inc |
JSPR |
51 |
0 |
-79 |
21 |
| Ladrx Corporation |
LADX |
1 |
0 |
-2 |
0 |
| Lexeo Therapeutics Inc |
LXEO |
141 |
0 |
-109 |
30 |
| Mesoblast Ltd |
MESO |
12,182 |
6 |
-88 |
201 |
| Molecular Partners Ag |
MOLN |
120 |
7 |
-62 |
115 |
| Orchard Therapeutics Plc |
ORTX |
3,814 |
22 |
-73 |
100 |
| Phoenix Biotech Acquisition Corp |
PBAXU |
36 |
0 |
-10 |
0 |
| Biomx Inc |
PHGE |
9 |
0 |
8 |
0 |
| Peak Bio Inc |
PKBO |
1 |
0 |
-3 |
0 |
| Mosaic Immunoengineering Inc |
PTSC |
0 |
0 |
-1 |
0 |
| Sab Biotherapeutics Inc |
SABS |
26 |
59 |
-34 |
63 |
| Scinai Immunotherapeutics Ltd |
SCNI |
3,344 |
0 |
7 |
24 |
| Seagen Inc |
SGEN |
43,034 |
2,300 |
-750 |
1,200 |
| Sorrento Therapeutics Inc |
SRNEQ |
18 |
51 |
-325 |
30 |
| Sutro Biopharma Inc |
STRO |
66 |
66 |
-245 |
201 |
| Springworks Therapeutics Inc |
SWTX |
0 |
0 |
-348 |
84 |
| Tscan Therapeutics Inc |
TCRX |
245 |
4 |
-131 |
49 |
| Turnstone Biologics Corp |
TSBX |
8 |
0 |
-63 |
50 |
| Tevogen Bio Holdings Inc |
TVGN |
200 |
0 |
-31 |
18 |
| Vir Biotechnology Inc |
VIR |
749 |
21 |
-578 |
201 |
| Zura Bio Limited |
ZURA |
169 |
0 |
-62 |
0 |
| Astrazeneca Plc |
AZN |
108,247 |
45,811 |
5,961 |
83,100 |
| Black Diamond Therapeutics Inc |
BDTX |
185 |
0 |
5 |
202 |
| Bristol myers Squibb Company |
BMY |
96,930 |
47,636 |
5,437 |
34,100 |
| Merck and Co Inc |
MRK |
202,048 |
63,922 |
17,451 |
72,000 |
| Mural Oncology Plc |
MURA |
43 |
0 |
-131 |
33 |
| Novartis Ag |
NVS |
239,576 |
46,660 |
14,854 |
109,000 |
| Pfizer Inc |
PFE |
139,724 |
62,463 |
7,912 |
88,000 |
|
SUBTOTAL |
1,241,033 |
347,245 |
57,790 |
446,372 |
|
